表紙:疼痛管理デバイスの世界市場 (~2026年):タイプ (神経刺激・SCS・TENS・RFアブレーション・輸液ポンプ)・用途 (神経障害性疼痛・癌性疼痛・顔面痛・MSK・片頭痛)・購入モード (OTC・処方箋)・地域別
市場調査レポート
商品コード
1036806

疼痛管理デバイスの世界市場 (~2026年):タイプ (神経刺激・SCS・TENS・RFアブレーション・輸液ポンプ)・用途 (神経障害性疼痛・癌性疼痛・顔面痛・MSK・片頭痛)・購入モード (OTC・処方箋)・地域別

Pain Management Devices Market by Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Neuropathy, Cancer, Facial, MSK, Migraine), Mode of Purchase (OTC, Prescription-based) & Region (NA, Europe, APAC) - Global Forecasts -2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 245 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円
疼痛管理デバイスの世界市場 (~2026年):タイプ (神経刺激・SCS・TENS・RFアブレーション・輸液ポンプ)・用途 (神経障害性疼痛・癌性疼痛・顔面痛・MSK・片頭痛)・購入モード (OTC・処方箋)・地域別
出版日: 2021年11月12日
発行: MarketsandMarkets
ページ情報: 英文 245 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の疼痛管理デバイスの市場規模は予測期間中8.6%のCAGRで推移し、2021年の22億米ドルから、2026年には33億米ドルの規模に成長すると予測されています。

タイプ別で見ると、神経刺激デバイスの部門が2020年に58.0%のシェアで最大の規模を示しています。慢性的な痛みを管理するための代替療法と比較した場合の利点、長期的な費用対効果、技術開発などの要因が同部門の成長を推進しています。また、用途別では、神経障害性疼痛の部門が31.4%のシェアで最大のシェアを示しています。神経障害性疼痛治療における高い有効性を示すエビデンスの存在、新規の神経障害性疼痛管理機器の開発、高齢化の進展、薬剤の副作用、償還制度のアベイラビリティなどの要因が同部門の成長に寄与しています。

当レポートでは、世界の疼痛管理デバイスの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、市場規模の推移・予測、タイプ・用途・購入モード・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 市場成長要因
    • 市場抑制要因
    • 市場機会
  • 規制状況
  • バリューチェーン分析
  • サプライチェーン分析
  • ポーターのファイブフォース分析
  • 産業動向
  • 貿易分析
  • COVID-19の影響

第6章 疼痛管理デバイス市場:タイプ別

  • 神経刺激デバイス
    • 経皮的電気刺激 (TENS) デバイス
    • 脊髄刺激
  • 輸液ポンプ
    • 髄腔内輸液ポンプ
    • 外部輸液ポンプ
  • アブレーションデバイス
    • RFアブレーションデバイス
    • 冷凍切除デバイス

第7章 疼痛管理デバイス市場:用途別

  • 神経障害性疼痛
  • 癌性疼痛
  • 顔面痛・片頭痛
  • 筋骨格痛
  • その他

第8章 疼痛管理デバイス市場:購入モード別

  • OTC
  • 処方箋

第9章 疼痛管理デバイス市場:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • 概要
  • 主要企業の収益シェア分析
  • 市場シェア分析
  • 企業評価クアドラント
  • 新興企業の企業評価クアドラント
  • 企業の製品フットプリント
  • 主要企業の地理的フットプリント
  • 競合シナリオ

第11章 企業プロファイル

  • 主要企業
    • MEDTRONIC
    • ABBOTT LABORATORIES
    • BOSTON SCIENTIFIC CORPORATION
    • STRYKER CORPORATION
    • BECTON, DICKINSON AND COMPANY
    • B. BRAUN MELSUNGEN AG
    • BAXTER INTERNATIONAL INC.
    • AVANOS MEDICAL, INC.
    • TELEFLEX, INC.
    • SMITHS MEDICAL
    • NIPRO CORPORATION
    • MOOG INC.
    • ATRICURE
    • NEVRO CORP.
    • MICREL MEDICAL DEVICES SA
    • MINDRAY MEDICAL INTERNATIONAL LIMITED
    • SHENZHEN MEDRENA BIOTECH CO., LTD.
    • EPIC MEDICAL
    • BIONESS
    • SOTERIX MEDICAL
  • その他の企業
    • INFUTRONIX SOLUTIONS LLC
    • GIMER MEDICAL
    • BLUEWIND MEDICAL
    • NEURONANO
    • MICROTRANSPONDER

第12章 付録

目次
Product Code: MD 4371

The global pain management devices market is projected to reach USD 3.3 billion by 2026 from USD 2.2 billion in 2021, at a CAGR of 8.6% during the forecast period Pain management devices are used to manage chronic and acute pain in patients suffering from various types of disease conditions, such as cancer, neurological disorders, and musculoskeletal disorders, among others. These devices restore the ability to do everyday activities, decrease the need for oral pain medications, and improve the quality of life of patients suffering from these conditions. However, product recalls and high procedural costs likely to challenge market growth in the coming years.

Neurostimulation devices to hold the largest segment of the market

Based on type, the pain management devices market is segmented into neurostimulation devices, infusion pumps, and ablation devices. In 2020, the neurostimulation segment accounted for 58.0% of the pain management devices market. Neurostimulation devices provide pain relief by disrupting pain signals traveling between the spinal cord and the brain. These devices can be either implantable or non-implantable in nature. Neuromodulation devices are further classified into transcutaneous electrical nerve stimulators (TENS) and spinal cord stimulators. The large share and high growth of this segment is attributed to advantages of neuromodulation as compared to alternative therapies for managing chronic pain, its long-term cost effectivity and technological developments in the neurostimulation devices segment.

Neuropathic pain to hold the largest share of the applications market

Based on application, the pain management devices market is segmented into neuropathic pain, musculoskeletal pain, cancer pain, facial pain & migraine, and other applications. The neuropathic pain segment accounted for the largest market share of 31.4% in 2020. The presence of substantial clinical evidences in the favor of high efficacy of pain management devices in neuropathic pain treatment, development of novel neuropathic pain management devices, rising aging population across the globe (geriatric population is at high risk of neuropathic pain due to the increased incidence of neuropathic pain associated with many age-related diseases), side effects of drugs used to treat neuropathic pain, and availability of reimbursement are fueling the adoption of pain management devices for neuropathic pain treatment are the major factors contributing to the growth of the pain management devices market for neuropathic pain applications.

The US to dominate the pain management devices market in North America

North America dominated the pain management devices market, with a share of 52.3% in 2020, followed by Europe and the Asia Pacific, Latin America, and Middle East & Africa. North America has been among the frontrunners in developing pain management devices services in the healthcare industry. The pain management devices market in the US is expected to offer growth opportunities in the coming years owing to the increasing adoption of pain management devices in ambulatory care centers. Many major global players are also based in the US, owing to which the country has become a center of innovation in the pain management devices market.

Breakdown of supply-side primary interviews: * By Company Type: Tier 1 - 60%, Tier 2 - 30%, and Tier 3 - 10% * By Designation: Director-level - 30%, C-level - 50%, and Others - 20% * By Region: North America - 45%, Europe - 15%, APAC -25%, Rest of the World -15%

Some of the prominent players operating in the pain management devices market are Medtronic PLC (Ireland), Boston Scientific (US), Abbott (US), Becton, Dickinson and Company (US), Baxter International (US), B. Braun Melsungen AG (Germany), Stryker (US), Smiths Medical (US), Moog Inc. (US), Avanos Medical, Inc. (US), Nipro Corporation (Japan), Atricure (US), Nevro Corp. (US), Micrel Medical Devices SA (Greece), InfuTronix Solutions LLC (US), Teleflex, Inc. (US), Mindray Medical International Limited (China), Shenzhen MedRena Biotech Co., Ltd. (China), Epic Medical (Singapore), Bioness (US), Microtransponder (US), Neuronano (Sweden), Gimer Medical (Taiwan), Bluewind Medical (Israel), Soterix Medical Inc. (US) and other players.

Research Coverage

This report studies the pain management devices market based on type, mode of purchase, and application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to two main geographies - source and destination.

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
    • 1.3.3 CURRENCY
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
  • 2.2 RESEARCH METHODOLOGY DESIGN
    • FIGURE 1 PAIN MANAGEMENT DEVICES MARKET: RESEARCH DESIGN
    • 2.2.1 SECONDARY RESEARCH
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.2.2.1 Key data from primary sources
      • 2.2.2.2 Key industry insights
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • 2.3 MARKET SIZE ESTIMATION
    • FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC PLC
    • FIGURE 7 REVENUE ANALYSIS OF THE TOP FIVE COMPANIES: PAIN MANAGEMENT DEVICES MARKET (2020)
    • FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE PAIN MANAGEMENT DEVICES MARKET (2021-2026)
    • FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 10 TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY
  • 2.5 MARKET SHARE ANALYSIS
  • 2.6 ASSUMPTIONS FOR THE STUDY
  • 2.7 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: PAIN MANAGEMENT DEVICES MARKET
  • 2.8 LIMITATIONS
    • 2.8.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.8.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 12 PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 NEUROSTIMULATION MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 INFUSION PUMP MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 15 ABLATION DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 16 PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 17 PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 18 GEOGRAPHIC SNAPSHOT: INFUSION PUMPS MARKET

4 PREMIUM INSIGHTS

  • 4.1 PAIN MANAGEMENT DEVICES MARKET OVERVIEW
    • FIGURE 19 GROWING DEMAND FOR LONG-TERM PAIN MANAGEMENT AMONG THE GERIATRIC POPULATION-PRIMARY MARKET DRIVER
  • 4.2 ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET SHARE, BY APPLICATION & REGION (2020)
    • FIGURE 20 NEUROSTIMULATION TO HOLD THE LARGEST SHARE OF THE ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET IN 2020
  • 4.3 PAIN MANAGEMENT DEVICES MARKET: GEOGRAPHIC MIX
    • FIGURE 21 THE US TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • 4.4 REGIONAL MIX: PAIN MANAGEMENT DEVICES MARKET
    • FIGURE 22 NORTH AMERICA DOMINATED THE MARKET IN 2020

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 23 PAIN MANAGEMENT DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Rising demand for chronic pain management in home care settings
      • 5.2.1.2 Growing number of surgical procedures performed
      • 5.2.1.3 Rising prevalence of neurological disorders
        • 5.2.1.3.1 Growing incidence of sports injuries and cancer
    • TABLE 2 COUNTRY-WISE CANCER INCIDENCE PER MILLION POPULATION, 2015-2019
      • 5.2.1.4 Established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries
    • 5.2.2 MARKET RESTRAINTS
      • 5.2.2.1 Product recalls
      • 5.2.2.2 High procedural and purchase cost of pain management devices
    • 5.2.3 MARKET OPPORTUNITIES
      • 5.2.3.1 High growth opportunities in emerging countries
    • TABLE 3 RISING INCOME LEVELS IN EMERGING COUNTRIES
      • 5.2.3.2 Expanding base of pain management clinics/centers across the globe
      • 5.2.3.3 Use of pain medications as the first line of treatment for pain management
      • 5.2.3.4 Stringent regulatory guidelines delay the adoption of novel devices
    • TABLE 4 PRESENCE OF ALTERNATIVE THERAPIES FOR PAIN MANAGEMENT IS A MAJOR MARKET CHALLENGE
  • 5.3 REGULATORY LANDSCAPE
    • TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING PAIN MANAGEMENT DEVICES
    • 5.3.1 NORTH AMERICA
      • 5.3.1.1 US
    • TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • FIGURE 24 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
      • 5.3.1.2 Canada
    • FIGURE 25 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
    • 5.3.2 EUROPE
    • FIGURE 26 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES
    • 5.3.3 ASIA PACIFIC
      • 5.3.3.1 Japan
    • TABLE 9 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
      • 5.3.3.2 China
    • TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.3.3.3 India
    • FIGURE 27 LATIN AMERICA: REGULATORY SCENARIO
      • 5.3.3.4 Brazil
    • FIGURE 28 BRAZIL: REGULATORY PROCESS FOR MEDICAL DEVICES
    • TABLE 11 BRAZIL: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
      • 5.3.3.5 Mexico
    • FIGURE 29 MEXICO: REGULATORY PROCESS FOR MEDICAL DEVICES
    • TABLE 12 MEXICO: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 30 PAIN MANAGEMENT DEVICES MARKET: VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN ANALYSIS
    • FIGURE 31 PAIN MANAGEMENT DEVICES MARKET: SUPPLY CHAIN ANALYSIS
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 13 PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 THREAT FROM NEW ENTRANTS
    • 5.6.2 THREAT FROM SUBSTITUTES
    • 5.6.3 BARGAINING POWER OF SUPPLIERS
    • 5.6.4 BARGAINING POWER OF BUYERS
    • 5.6.5 COMPETITIVE RIVALRY
  • 5.7 INDUSTRY TRENDS
    • 5.7.1 WEARABLE DEVICES
    • 5.7.2 RISING POPULARITY OF RECHARGEABLE SPINAL CORD STIMULATORS
  • 5.8 TRADE ANALYSIS
    • 5.8.1 TRADE ANALYSIS FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES
    • TABLE 14 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2016-2020 (USD BILLION)
  • 5.9 COVID-19 IMPACT ON THE PAIN MANAGEMENT DEVICES MARKET

6 PAIN MANAGEMENT DEVICES MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 15 PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 6.2 NEUROSTIMULATION DEVICES
    • TABLE 16 NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 17 NEUROSTIMULATION DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) DEVICES
      • 6.2.1.1 Extensive use in healthcare, low cost, and ease of use will favor market growth
    • TABLE 18 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.2 SPINAL CORD STIMULATION
      • 6.2.2.1 Rising incidence of indications and efficacy & reversibility of procedure have supported the adoption of SCS
    • TABLE 19 SPINAL CORD STIMULATION DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 6.3 INFUSION PUMPS
    • 6.3.1 HIGH USE OF INFUSION PUMPS IN POSTOPERATIVE PAIN MANAGEMENT
    • TABLE 20 INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 21 INFUSION PUMPS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.2 INTRATHECAL INFUSION PUMPS
    • TABLE 22 INTRATHECAL INFUSION PUMPS DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.3 EXTERNAL INFUSION PUMPS
    • TABLE 23 EXTERNAL INFUSION PUMPS DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 6.4 ABLATION DEVICES
    • TABLE 24 ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 25 ABLATION DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • 6.4.1 RF ABLATION DEVICES
    • TABLE 26 RF ABLATION DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • 6.4.2 CRYOABLATION DEVICES
    • TABLE 27 CRYOABLATION DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)

7 PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 28 PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
  • 7.2 NEUROPATHIC PAIN
    • 7.2.1 HIGH PREVALENCE OF DISEASES ASSOCIATED WITH NEUROPATHIC PAIN
    • TABLE 29 NEUROPATHIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.3 CANCER PAIN
    • TABLE 30 CANCER PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.4 FACIAL PAIN & MIGRAINE
    • TABLE 31 FACIAL PAIN & MIGRAINE MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.5 MUSCULOSKELETAL PAIN
    • TABLE 32 MUSCULOSKELETAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.6 OTHER APPLICATIONS
    • TABLE 33 OTHER PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)

8 PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE

  • 8.1 INTRODUCTION
    • TABLE 34 PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
  • 8.2 OVER-THE-COUNTER PAIN MANAGEMENT DEVICES
    • 8.2.1 OTC PAIN MANAGEMENT DEVICES UNFOLD NEW GROWTH AVENUES
    • TABLE 35 OVER-THE-COUNTER PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 PRESCRIPTION-BASED PAIN MANAGEMENT DEVICES
    • TABLE 36 PRESCRIPTION-BASED PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)

9 PAIN MANAGEMENT DEVICES MARKET, BY REGION

  • 9.1 INTRODUCTION
    • FIGURE 32 PAIN MANAGEMENT DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • TABLE 37 GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 33 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SNAPSHOT
    • TABLE 38 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 39 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 40 NORTH AMERICA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 41 NORTH AMERICA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 42 NORTH AMERICA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 43 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 44 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 9.2.1 THE US
      • 9.2.1.1 The US is expected to hold the leading position in the market due to the rising geriatric population, increasing prevalence of chronic diseases, and the growing home healthcare market
    • TABLE 45 KEY MACROINDICATORS FOR THE US
    • TABLE 46 US: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 47 US: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 48 US: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 49 US: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 50 US: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 51 US: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Increasing incidence of chronic pain indications to support the adoption of pain management devices in Canada
    • TABLE 52 KEY MACROINDICATORS FOR CANADA
    • TABLE 53 CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 54 CANADA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 55 CANADA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 56 CANADA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 57 CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 58 CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 59 EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 60 EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 61 EUROPE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 62 EUROPE: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 63 EUROPE: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 64 EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 65 EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Presence of leading pain management device manufacturers to drive market growth in Germany
    • TABLE 66 KEY MACROINDICATORS FOR GERMANY
    • TABLE 67 GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 68 GERMANY: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 69 GERMANY: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 70 GERMANY: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 71 GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 72 GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 9.3.2 FRANCE
    • TABLE 73 KEY MACROINDICATORS FOR FRANCE
    • TABLE 74 FRANCE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 75 FRANCE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 76 FRANCE: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 77 FRANCE: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 78 FRANCE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 79 FRANCE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 9.3.3 THE UK
      • 9.3.3.1 High burden of chronic pain in the country to propel the growth of the pain management devices market
    • TABLE 80 KEY MACROINDICATORS FOR THE UK
    • TABLE 81 UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 82 UK: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 83 UK: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 84 UK: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 85 UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 86 UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Growing demand for cost-effective home care services to support market growth
    • TABLE 87 KEY MACROINDICATORS FOR ITALY
    • TABLE 88 ITALY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 89 ITALY: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 90 ITALY: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 91 ITALY: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 92 ITALY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 93 ITALY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Rising prevalence of cancer to support the market for pain management devices market in Spain
    • TABLE 94 KEY MACROINDICATORS FOR SPAIN
    • TABLE 95 SPAIN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 96 SPAIN: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 97 SPAIN: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 98 SPAIN: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 99 SPAIN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 100 SPAIN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 101 ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 102 ROE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 103 ROE: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 104 ROE: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 105 ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 106 ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 34 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SNAPSHOT
    • TABLE 107 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 108 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 109 ASIA PACIFIC: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 110 ASIA PACIFIC: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 111 ASIA PACIFIC: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 112 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 113 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 9.4.1 JAPAN
      • 9.4.1.1 Large geriatric population in the country is driving the demand for infusion pumps
    • TABLE 114 KEY MACRO INDICATORS FOR JAPAN
    • TABLE 115 JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 116 JAPAN: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 117 JAPAN: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 118 JAPAN: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 119 JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 120 JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 Growing investments in healthcare infrastructure development in the country to drive market growth in China
    • TABLE 121 KEY MACRO INDICATORS FOR CHINA
    • TABLE 122 CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 123 CHINA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 124 CHINA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 125 CHINA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 126 CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 127 CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 High prevalence of lifestyle diseases in the country to drive the market for pain management devices market
    • TABLE 128 KEY MACRO INDICATORS FOR INDIA
    • TABLE 129 INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 130 INDIA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 131 INDIA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 132 INDIA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 133 INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 134 INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC
      • 9.4.4.1 High prevalence of chronic diseases in the region to drive the market for pain management devices
    • FIGURE 35 PREVALENCE OF DIABETES IN SOUTHEAST ASIA (2018/2019)
    • TABLE 135 ESTIMATED NUMBER OF CANCER CASES IN SOUTHEAST ASIAN COUNTRIES, 2020 VS. 2040 (IN THOUSAND)
    • FIGURE 36 HEALTHCARE EXPENDITURE (% GDP) IN SOUTHEAST ASIA (2018)
    • FIGURE 37 GERIATRIC POPULATION IN 2019 (% OF TOTAL POPULATION)
    • TABLE 136 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 137 REST OF ASIA PACIFIC: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 138 REST OF ASIA PACIFIC: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 139 REST OF ASIA PACIFIC: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 140 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 141 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
  • 9.5 LATIN AMERICA
    • TABLE 142 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 143 LATIN AMERICA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 144 LATIN AMERICA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 145 LATIN AMERICA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 146 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 147 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
  • 9.6 MIDDLE EAST AND AFRICA
    • 9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
    • TABLE 148 MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 149 MIDDLE EAST & AFRICA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 150 MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 151 MIDDLE EAST & AFRICA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 152 MIDDLE EAST AND AFRICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 153 MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • FIGURE 38 KEY DEVELOPMENTS OF PROMINENT PLAYERS OPERATING IN PAIN MANAGEMENT DEVICES MARKET (2020-2021)
  • 10.2 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
    • FIGURE 39 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE PAIN MANAGEMENT DEVICES MARKET
  • 10.3 MARKET SHARE ANALYSIS
    • FIGURE 40 PAIN MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2020
  • 10.4 COMPANY EVALUATION QUADRANT
    • 10.4.1 STARS
    • 10.4.2 EMERGING LEADERS
    • 10.4.3 PERVASIVE PLAYERS
    • 10.4.4 PARTICIPANTS
    • FIGURE 41 PAIN MANAGEMENT DEVICES MARKET: COMPANY EVALUATION QUADRANT (2020)
  • 10.5 COMPANY EVALUATION QUADRANT FOR START-UPS
    • 10.5.1 PROGRESSIVE COMPANIES
    • 10.5.2 DYNAMIC COMPANIES
    • 10.5.3 STARTING BLOCKS
    • 10.5.4 RESPONSIVE COMPANIES
    • FIGURE 42 PAIN MANAGEMENT DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS (2020)
  • 10.6 COMPANY PRODUCT FOOTPRINT
    • TABLE 154 PRODUCT PORTFOLIO ANALYSIS: PAIN MANAGEMENT DEVICES MARKET
  • 10.7 GEOGRAPHIC FOOTPRINT OF THE MAJOR PLAYERS IN THE PAIN MANAGEMENT DEVICES MARKET
    • TABLE 155 GEOGRAPHIC REVENUE MIX: PAIN MANAGEMENT DEVICES MARKET (2020)
  • 10.8 COMPETITIVE SCENARIO
    • 10.8.1 PRODUCT LAUNCHES
    • TABLE 156 PRODUCT LAUNCHES (JANUARY 2018 - JUNE 2021)
    • 10.8.2 DEALS
    • TABLE 157 DEALS (JANUARY 2018-JUNE 2021)
    • 10.8.3 OTHER DEVELOPMENTS
    • TABLE 158 OTHER DEVELOPMENTS (JANUARY 2018- JUNE 2021)

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 11.1.1 MEDTRONIC
    • TABLE 159 MEDTRONIC PLC: BUSINESS OVERVIEW
    • FIGURE 43 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
    • 11.1.2 ABBOTT LABORATORIES
    • TABLE 160 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 44 ABBOTT LABORATORIES: COMPANY SNAPSHOT
    • TABLE 161 ABBOTT LABORATORIES: PRODUCT OFFERINGS
    • 11.1.3 BOSTON SCIENTIFIC CORPORATION
    • TABLE 162 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
    • FIGURE 45 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
    • TABLE 163 BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERINGS
    • 11.1.4 STRYKER CORPORATION
    • TABLE 164 STRYKER: BUSINESS OVERVIEW
    • FIGURE 46 STRYKER CORPORATION: COMPANY SNAPSHOT
    • TABLE 165 STRYKER: PRODUCT OFFERINGS
    • 11.1.5 BECTON, DICKINSON AND COMPANY
    • TABLE 166 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 47 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
    • 11.1.6 B. BRAUN MELSUNGEN AG
    • TABLE 167 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW
    • FIGURE 48 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020)
    • 11.1.7 BAXTER INTERNATIONAL INC.
    • TABLE 168 BAXTER INTERNATIONAL INC.: BUSINESS OVERVIEW
    • FIGURE 49 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2020)
    • 11.1.8 AVANOS MEDICAL, INC.
    • TABLE 169 AVANOS MEDICAL, INC.: BUSINESS OVERVIEW
    • FIGURE 50 AVANOS MEDICAL, INC.: COMPANY SNAPSHOT (2020)
    • 11.1.9 TELEFLEX, INC.
    • TABLE 170 TELEFLEX, INC.: BUSINESS OVERVIEW
    • FIGURE 51 TELEFLEX, INC.: COMPANY SNAPSHOT (2020)
    • 11.1.10 SMITHS MEDICAL
    • TABLE 171 SMITHS MEDICAL: BUSINESS OVERVIEW
    • FIGURE 52 SMITHS MEDICAL: COMPANY SNAPSHOT (2020)
    • 11.1.11 NIPRO CORPORATION
    • TABLE 172 NIPRO CORPORATION: BUSINESS OVERVIEW
    • FIGURE 53 NIPRO CORPORATION: COMPANY SNAPSHOT (2019)
    • 11.1.12 MOOG INC.
    • TABLE 173 MOOG INC.: BUSINESS OVERVIEW
    • FIGURE 54 MOOG INC.: COMPANY SNAPSHOT (2020)
    • 11.1.13 ATRICURE
    • TABLE 174 ATRICURE: BUSINESS OVERVIEW
    • FIGURE 55 ATRICURE: COMPANY SNAPSHOT
    • TABLE 175 ATRICURE: PRODUCT OFFERINGS
    • 11.1.14 NEVRO CORP.
    • TABLE 176 NEVRO CORP: BUSINESS OVERVIEW
    • FIGURE 56 NEVRO CORP.: COMPANY SNAPSHOT
    • TABLE 177 NEVRO CORP: PRODUCT OFFERINGS
    • 11.1.15 MICREL MEDICAL DEVICES SA
    • TABLE 178 MICREL MEDICAL DEVICES SA: BUSINESS OVERVIEW
    • 11.1.16 MINDRAY MEDICAL INTERNATIONAL LIMITED
    • TABLE 179 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW
    • 11.1.17 SHENZHEN MEDRENA BIOTECH CO., LTD.
    • TABLE 180 SHENZHEN MEDRENA BIOTECH CO., LTD.: BUSINESS OVERVIEW
    • 11.1.18 EPIC MEDICAL
    • TABLE 181 EPIC MEDICAL: BUSINESS OVERVIEW
    • 11.1.19 BIONESS
    • 11.1.20 SOTERIX MEDICAL
  • 11.2 OTHER PLAYERS
    • 11.2.1 INFUTRONIX SOLUTIONS LLC
    • TABLE 182 INFUTRONIX SOLUTIONS LLC: BUSINESS OVERVIEW
    • 11.2.2 GIMER MEDICAL
    • 11.2.3 BLUEWIND MEDICAL
    • 11.2.4 NEURONANO
    • 11.2.5 MICROTRANSPONDER
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS